Unlock Premium Data: Up to 50% Off InvestingProCLAIM SALE

Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling

Published 06/01/2023, 13:59
Updated 06/01/2023, 15:10
© Reuters.  Crocs, Lamb Weston And These 3 Stocks Insiders Are Selling
CROX
-
IXIC
-
UTHR
-
TGTB34
-
DBX
-

Benzinga - The Nasdaq Composite dropped around 150 points on Thursday. Investors, meanwhile, focused on some notable insider trades.

When insiders sell shares, it indicates their concern in the company’s prospects or that they view the stock as being overpriced. Either way, this signals an opportunity to go short on the stock. Insider sales should not be taken as the only indicator for making an investment or trading decision. At best, it can lend conviction to a selling decision.

Below is a look at a few recent notable insider sales. For more, check out Benzinga's insider transactions platform.

Moody's

  • The Trade: Moody's Corporation (NYSE: MCO) Director Raymond W McDaniel sold a total of 7,500 shares at an average price of $274.88. The insider received around $2.06 million from selling those shares.
  • What’s Happening: Morgan Stanley (NYSE:MS) maintained Moody's with an Equal-Weight and lowered the price target from $294 to $293.
  • What Moody's Does: Moody's, along with S&P Ratings, is a leading provider of credit ratings on fixed income securities.
Read More: Why Fear Level Among US Investors Is Decreasing

Dropbox

  • The Trade: Dropbox, Inc. (NASDAQ: DBX) CFO Timothy Regan sold a total of 2,000 shares at an average price of $22.56. The insider received around $45.12 thousand as a result of the transaction.
  • What’s Happening: Jefferies downgraded Dropbox from Buy to Hold and lowered the price target from $28 to $25.
  • What Dropbox Does: Dropbox is a leading provider of cloud-storage and content collaboration tools with an emphasis on individuals and SMB.
Have a look at our premarket coverage here

United Therapeutics

  • The Trade: United Therapeutics Corporation (NASDAQ: UTHR) EVP and General Counsel Paul Mahon sold a total of 12,000 shares at an average price of $197.04. The insider received around $2.36 million from selling those shares.
  • What’s Happening: UBS initiated coverage on United Therapeutics with a Buy rating and announced a price target of $320.
  • What United Therapeutics Does: United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs.

Lamb Weston Holdings

  • The Trade: Lamb Weston Holdings, Inc. (NYSE: LW) SVP, Gen Counsel Eryk J Spytek sold a total of 19,080 shares at an average price of $88.22. The insider received around $1.68 million from selling those shares.
  • What’s Happening: Lamb Weston reported better-than-expected Q2 EPS and sales results and raised FY23 guidance above estimates.
  • What Lamb Weston Does: Lamb Weston is the world's second-largest producer of branded and private-label frozen potato products, such as French fries, sweet potato fries, tater tots, diced potatoes, mashed potatoes, hash browns, and chips.

Crocs

  • The Trade: Crocs, Inc. (NASDAQ: CROX) Executive Vice President Daniel Hart sold a total of 10,000 shares at an average price of $110.00. The insider received around $1.1 million from selling those shares.
  • What’s Happening: Piper Sandler, last month, maintained Crocs with an Overweight and raised the price target from $95 to $118.
  • What Crocs Does: Crocs Inc is engaged in the design, development, marketing, distribution, and sale of casual lifestyle footwear accessories for men, women, and children.
© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.